VN

Vivek Narwal

Active Director Director DIN 09455596
DIN 09455596 First appointment Jan 2022 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jan 2022
Shareholding value Locked Premium profile

About Vivek Narwal

Vivek Narwal has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Chyren Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09455596
Primary Designation Director
First Appointment 03 Jan 2022
Oldest Company Age 4 yrs

Current companies

Company Designation Appointment Founded Status
Director 03 Jan 2022 2021 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Chyren Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vivek Narwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vivek Narwal

Vivek Narwal has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Chyren Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Vivek Narwal is associated with 1 company as Director.

Vivek Narwal has expertise in General Business.

Vivek Narwal has 4 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available